Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.

Εμφάνιση άλλων εκδόσεων (2)

BACKGROUND: Rimonabant is a selective type 1 cannabinoid (CB1) receptor antagonist. It may assist with smoking cessation by restoring the balance of the endocannabinoid system, which can be disrupted by prolonged use of nicotine. Rimonabant also seeks to address many smokers' reluctance to pers...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Cahill, K, Ussher, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2007

Παρόμοια τεκμήρια

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2007)

Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2007)

Cannabinoid type 1 receptor antagonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2011)

Cannabinoid type 1 receptor antagonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2011)

Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.
ανά: Horder, J, κ.ά.
Έκδοση: (2012)

Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing
ανά: Horder, J, κ.ά.
Έκδοση: (2012)

The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol
ανά: José Antonio López-Moreno, κ.ά.
Έκδοση: (2007-02-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
ανά: Taryn Bosquez-Berger, κ.ά.
Έκδοση: (2023-08-01)

Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.
ανά: Horder, J, κ.ά.
Έκδοση: (2009)

Opioid antagonists for smoking cessation
ανά: David, S, κ.ά.
Έκδοση: (2009)

Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant
ανά: Heppenstall Charlotte, κ.ά.
Έκδοση: (2012-07-01)

Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.
ανά: Horder, J, κ.ά.
Έκδοση: (2010)

Context-dependent effects of the CB1 receptor antagonist rimonabant on morphine-induced behavioral sensitization in female mice
ανά: Eduardo A. V. Marinho, κ.ά.
Έκδοση: (2023-02-01)

CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats
ανά: Li Zhao, κ.ά.
Έκδοση: (2021-04-01)

Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2007)

Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2011)

Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2008)

Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2012)

Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2010)

Opioid antagonists for smoking cessation
ανά: David, S, κ.ά.
Έκδοση: (2013)

Nicotine receptor partial agonists for smoking cessation.
ανά: Cahill, C, κ.ά.
Έκδοση: (2016)

Potential role of the endocannabinoid receptor antagonist rimonabant in the management of cardiometabolic risk: a narrative review of available data
ανά: Kirk A Bronander, κ.ά.
Έκδοση: (2007-05-01)

Veraliprida y rimonabant
ανά: Flavia Vidal
Έκδοση: (2007-09-01)

Nicotine receptor partial agonists for smoking cessation
ανά: Kate Cahill, κ.ά.

Workplace interventions for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2014)

Workplace interventions for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2008)

Exercise interventions for smoking cessation
ανά: Ussher, M, κ.ά.
Έκδοση: (2019)

Mecamylamine (a nicotine antagonist) for smoking cessation.
ανά: Lancaster, T, κ.ά.
Έκδοση: (2000)

Competitions and incentives for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2011)

Pharmacological treatments for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2014)

Competitions and incentives for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2008)

Competitions and incentives for smoking cessation
ανά: Cahill, K, κ.ά.
Έκδοση: (2011)

Rimonabant: From RIO to Ban
ανά: Amir H. Sam, κ.ά.
Έκδοση: (2011-01-01)

Rimonabant for treating tobacco dependence
ανά: Michael B Steinberg, κ.ά.
Έκδοση: (2007-07-01)

Antidepressants for smoking cessation.
ανά: Hughes, JR, κ.ά.
Έκδοση: (2014)

Quit and Win contests for smoking cessation
ανά: Cahill, K, κ.ά.
Έκδοση: (2008)

Quit and Win contests for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2008)

Quit and Win contests for smoking cessation.
ανά: Cahill, K, κ.ά.
Έκδοση: (2008)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat
ανά: Alireza Komaki, κ.ά.
Έκδοση: (2014-07-01)

Motivational interviewing for smoking cessation.
ανά: Lai, D, κ.ά.
Έκδοση: (2010)